1. Home
  2. Labeler Index
  3. Dispensing Solutions, Inc.
  4. 66336-567
  5. Product Images: Gabapentin

Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Gabapentin NDC 66336-567 by Dispensing Solutions, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

NDC 66336-0439-XX - NDC 66336 0439 XX WESTWARD

NDC 66336-0439-XX - NDC 66336 0439 XX WESTWARD

This is a description of a medication called Gabapentin 300 mg, which is available as yellow capsules with the imprint "West-ward 993". It is distributed by West-Ward Pharmaceutical Corp. and the product ID is 66336-0439-XX. It should be taken orally every few hours, but may cause dizziness or drowsiness. The medication should not be taken with Maalox. The lot number is 00000, and its pedigree number is 80656366. It should be stored at 68°F and kept out of reach of children. The medication is dispensed in a tight/light resistant container, and the description includes information about how it was packaged exclusively in Santa Ana, CA 92704.*

NDC 66336-0567-XX - NDC 66336 0567 XX West Ward

NDC 66336-0567-XX - NDC 66336 0567 XX West Ward

This is a bulk source data for Gabapentin 100mg capsules distributed by West-Ward Pharmaceutical Corp. The product ID is grey capsule imprinted with West-ward 991. The bulk source NDC is 00143-9992-01, the MFR. Lot and pedigree numbers are not available. The medication should be dispensed in a tight/light resistant container and taken orally every specified interval. The medication may cause dizziness or drowsiness and should not be taken with Maalox. The package contains XX capsules, and the RX number is 24354696. The medication guide should be dispensed with the prescription. The product should be stored at 68°- 77° F.*

Structural formula - gabapentin capsules 1

Structural formula - gabapentin capsules 1

Figure 1. Weekly Mean Pain Score (Observed Cases in ITT Population): Study 1 - gabapentin capsules 2

Figure 1. Weekly Mean Pain Score (Observed Cases in ITT Population): Study 1 - gabapentin capsules 2

Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - gabapentin capsules 3

Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - gabapentin capsules 3

Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies - gabapentin capsules 4

Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies - gabapentin capsules 4

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference From Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥ 12 Years of Age with Partial Seizures - gabapentin capsules 5

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference From Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥ 12 Years of Age with Partial Seizures - gabapentin capsules 5

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.